Date  |
|
| Apr 30, 2020 |
Guided Therapeutics and FDA Meet; Agree on Path Forward in Approval Process |
| Feb 18, 2020 |
Guided Therapeutics Files Pre-Submission Document with U.S. FDA Detailing Clinical Plan to Support Approval |
| Jan 28, 2020 |
Guided Therapeutics Plans Growth for 2020 After Closing Significant Financing |
| Jan 06, 2020 |
Guided Therapeutics Raises Funds Aimed at Increasing International Sales and Restarting US FDA Approval Process |
| Jun 05, 2019 |
Guided Therapeutics Reports New Progress with Chinese FDA and Increased Sales Forecast from Shandong Medical Device Technology Company |
| Apr 02, 2019 |
Guided Therapeutics Receives $2.5 Million Purchase Order from Chinese Partner Shandong Medical Device Technology Company |
| Mar 28, 2019 |
Guided Therapeutics Reports Significant Progress in Eliminating Variable Rate Convertible Loans and Restructuring Capitalization; Announces Reverse Stock Split |
| Dec 18, 2018 |
Central/Eastern European/Russian Distributor Expands LuViva Program by Signing Manufacturing, Supply and Royalty Agreement; Projects Purchases of $30 Million over 5 Years |
| Dec 04, 2018 |
Guided Therapeutics Reports Significant Reductions in Debt and Operating Expenses |
| Nov 26, 2018 |
Indonesia Places Significant Order for New LuViva Devices and Single-Use Cervical Guides |